Kuros appoints Dr. Fritz Kunz as chairman of the the company board

New Chief Operating Officer to Join Executive Management Team

16-Apr-2007

Kuros AG announced the appointment of Dr Fritz Kunz as Chairman of the Company Board and Dr Edward Currie as Chief Operating Officer.

Dr Fritz Kunz is an industry professional, having held senior operating and Board positions at a number of medical technology and biotechnology companies. He is currently a Board Member of two Swiss companies, Speedel, where he acts as Chairman and SenTec. Dr Kunz was previously the CEO and a Board Member of Institut Straumann AG. Before joining Straumann in 1994, Dr Kunz was Head of Finance and Administration at STRATEC Medical. Dr Kunz's earlier career was spent at Sandoz Pharma AG, where he held positions of increasing responsibility and seniority.

Dr Edward Currie, who joined Kuros earlier this year, also brings a solid background in Pharma and Biotech. A British-trained medical doctor, Dr Currie has 19 years of international Pharma experience, with F.Hoffmann-La Roche in global positions including Medical Director of the Biotech Business Unit, Global Business Leader for the monoclonal antibody MabThera(r), and Head of Disease Management; at Eli Lilly, as International Clinical Research Physician and at IBM as a managing consultant in pharmaceuticals.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances